Zobrazeno 1 - 3
of 3
pro vyhledávání: '"clinical threshold value"'
Autor:
Nastya Kharlamova, Christina Hermanrud, Nicky Dunn, Malin Ryner, Karen Hambardzumyan, Nancy Vivar Pomiano, Per Marits, Inger Gjertsson, Saedis Saevarsdottir, Rille Pullerits, Anna Fogdell-Hahn
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
A subgroup of patients treated with infliximab lose response to the treatment and one reason for this is the development of anti-drug antibodies (ADA). If used optimally, measuring drug and ADA level could lead to a more personalized and efficient tr
Externí odkaz:
https://doaj.org/article/79dbf46073304c1b828a8088bc48196f
Autor:
Kharlamova, Nastya, Hermanrud, Christina, Dunn, Nicky, Ryner, Malin, Hambardzumyan, Karen, Vivar Pomiano, Nancy, Marits, Per, Gjertsson, Inger, Saevarsdottir, Saedis, Pullerits, Rille, Fogdell-Hahn, Anna
Publikováno v:
Frontiers in Immunology
Publisher's version (útgefin grein)
A subgroup of patients treated with infliximab lose response to the treatment and one reason for this is the development of anti-drug antibodies (ADA). If used optimally, measuring drug and ADA level could le
A subgroup of patients treated with infliximab lose response to the treatment and one reason for this is the development of anti-drug antibodies (ADA). If used optimally, measuring drug and ADA level could le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::291be7db203b1fd807278d3fd6d2b219
https://hdl.handle.net/20.500.11815/2403
https://hdl.handle.net/20.500.11815/2403
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.